Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia

Inclusion Criteria: Verified diagnosis of schizophrenic or affective spectrum (schizophrenia, schizoaffective disorder, bipolar disorder, major depressive disorder) Patient's ability (possibly accompanied by caregivers) to undergo diagnostic and therapeutic procedures; The presence of residual catatonia in the form of such psychomotor anomalies as: * disorganisation of thinking with speech disturbance with verbigerations and/or sperrungs * hypo- and hyperkinetic psychomotor phenomena; * substupor without disturbance of consciousness; * elective mutism; * echo phenomena (echolalia and/or echopraxia); * phenomena of "wax flexibility" * speech and behavioral stereotypy * pathetic exaltation phenomena * the phenomenon of irritative asthenia * dysuric phenomena (monotonous activity and rigidity of affect) Exclusion Criteria: * patient's refusal to participate in the study * acute hallucinatory-delusional symptoms * suicide risk * a patient taking prohibited therapy products * neuroleptic complications of antipsychotic therapy * irritative asthenia * dysuric phenomena by the type of monotonous activity and rigidity of affect